Sort
64,565 grants matching “drug discovery”
Target discovery and combination therapy in KRAS mutant cancer
$473,481Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Overcoming resistance to targeted therapy in cancer
$473,472Levi Alexander Garraway · Dana-Farber Cancer Inst · R35 · FY2015 · CA
Expanding the Chemical Biology of K2P Channels with Selective Cellular and In vivo Probes
$473,430Adam R Renslo · University Of California, San Francisco · R01 · FY2020 · MH
Biomolecular Recognition and Binding Mechanisms
$473,373Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Bayesian Network-Based Integrative Genomics Methods for Precision Medicine
$473,363Jeffrey S. Morris · University Of Pennsylvania · R01 · FY2021 · CA
Preclinical Development of First-in-Class NDUFS7 Antagonists for the Treatment of Pancreatic Cancer
$473,270Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Integrated Instrument System for Single Cell Genomics
$473,255Leonid S Metelitsa · Baylor College Of Medicine · S10 · FY2015 · OD
Rock Inhibition as Therapy for Cerebral Cavernous Malformation
$473,253Issam A Awad · University Of Chicago · R01 · FY2014 · NS
Chemistry Core
$473,246Douglas E Frantz · Ut Southwestern Medical Center · P01 · FY2011 · CA
Metabolic Imaging of the Cardioprotective Effects of Alcohol and ALDH2 Activators
$473,237Daniel M Spielman · Stanford University · R01 · FY2011 · AA
High-Content Screen to Identify Small Molecule Therapeutics that Reduce Aberrant Lipid Accumulation in APOE4 Alzheimer's Disease
$473,216Kelvin T Lam · Mcm6 Therapeutics, Inc. · R41 · FY2024 · AG
Regulatory T cells in Autoimmune Disease
$473,150Charles Garrison Fathman · Yale University · U19 · FY2011 · AI
Resources for Teleost Gene Duplicates and Human Disease
$473,109John Harvey Postlethwait · University Of Oregon · R01 · FY2016 · OD
Regulation of apoptosis by PI 3-kinase/Akt signaling
$473,090Geoffrey M Cooper · Boston University (Charles River Campus) · R01 · FY2008 · CA
MECHANISMS OF POL II ELONGATION IN DIFFUSE MIDLINE GLIOMA
$473,032Jamie N. Anastas · Baylor College Of Medicine · R01 · FY2023 · NS
Terpene Condensation Reactions
$472,991Charles Dale Poulter · University Of Utah · R56 · FY2009 · GM
Development of cell-free DNA assays for HCC screening and liquid biopsy
$472,981Ying-Hsiu Su · Baruch S. Blumberg Institute · R01 · FY2017 · CA
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) - Moderna Boost {Supplement #5}
$472,962David S Stephens · Emory University · UM1 · FY2021 · AI
Signature-Directed Combination Mitigator Therapy Based on GS-Nitroxides
$472,947Joel S Greenberger · University Of Pittsburgh At Pittsburgh · U19 · FY2017 · AI
HIV Tat and Opiate-mediated aberrations in glial-neuronal crosstalk: Implications for the role of extracellular RNA in HAND
$472,930Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2025 · DA
Significance of UBIAD1 in Regulation of HMG CoA Reductase Degradation, Mevalonate Metabolism, and Menaquinone-4 Synthesis
$472,924Russell Alfred Debose-Boyd · Ut Southwestern Medical Center · R01 · FY2023 · GM
Coordination of stress-adaptive cell states by CRIPTO in breast cancer heterogeneity and progression
$472,921Benjamin T Spike · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
E3 ubiquitin ligase RNF145 in airway smooth muscle functions and in asthma
$472,898Pawan Sharma · Thomas Jefferson University · R01 · FY2023 · HL
E3 ubiquitin ligase RNF145 in airway smooth muscle functions and in asthma
$472,898Pawan Sharma · Thomas Jefferson University · R01 · FY2022 · HL
Inflammation in Vascular Injury and Repair
$472,847Daniel I Simon · Case Western Reserve University · R37 · FY2012 · HL